November 13, 2026

New WHO Recommendation Changes the Assessment of Physical Activity

New WHO Recommendation Changes the Assessment of Physical Activity

A team led by researchers at the German Cancer Research Center (DKFZ) shows that the WHO’s updated physical activity recommendations fundamentally change the assessment of physical endurance activity. While only 35 percent of respondents met the recommended physical activity targets under the previous WHO guidelines, 99 percent did so under the recommendations in effect since 2020.

The reason lies in a significant change to the WHO guidelines: Endurance activity no longer needs to be performed for at least ten consecutive minutes to count toward the recommendation. Even short bursts of activity—such as climbing stairs or a brisk sprint to catch the bus—are now taken into account. In doing so, the WHO is taking into account new scientific findings indicating that even short periods of physical activity make a positive contribution to health.

For the study, physical activity data from more than 63,000 NAKO* participants—collected using accelerometers—were analyzed. However, the results raise questions: If nearly everyone meets the physical activity recommendations, are these recommendations still a suitable benchmark for adequate physical activity? The researchers point out that while the new guidelines better reflect the health benefits of short periods of activity, they also alter the significance of the recommendations. Differences between active and less active population groups become less pronounced, and comparisons with older studies are now only possible to a limited extent.

According to the authors, the study’s findings could indicate that the current thresholds for modern, objective measurement methods—such as accelerometers—should be reviewed and, if necessary, adjusted in the future. The results therefore do not necessarily mean that the population is getting enough physical activity today—rather, the study shows how significantly the assessment has changed due to new scientific findings and altered measurement methods.

“Accelerometers are helpful because potential memory lapses among study participants during interviews can skew the results,” explains senior author Karen Steindorf. The researcher therefore recommends using both the previous and the new assessment methods in parallel in future studies. This would allow for a better understanding of trends in physical activity behavior and enable more targeted planning of measures to promote physical activity.

It is also important to note that the study examined only the recommended endurance activities. The WHO, however, also recommends muscle-strengthening exercises. “For most people, however, strength training is the main barrier preventing them from following the overall recommendations for physical activity,” qualifies lead author Julian Brummer. Therefore, no conclusions can be drawn from this study regarding whether the WHO’s overall recommendations are being met. “However, our research on this topic is in full swing,” adds Brummer.

* NAKO Health Study: Germany’s largest long-term study on common diseases. The DKFZ is a member of NAKO e.V., which conducts the study.

Publication:

Julian Brummer, Michael J. Stein, Hansjörg Baurecht, Mirko Brandes, Christoph Buck, Antje Hebestreit, Lilian Krist, Michael Leitzmann, Andrea Weber, Volker Harth, Jana-Kristin Heise, Verena Katzke, Thomas Keil, Alexander Kluttig, Claudia Meinke-Franze, Rafael Mikolajczyk, Ute Mons, Katharina Nimptsch, Nadia Obi, Cara Övermöhle, Annette Peters, Tobias Pischon, Börge Schmidt, Matthias B. Schulze, Henry Völzke, Stefan N. Willich, Florian Herbolsheimer, Karen Steindorf: Implications of the 10-minute bout requirement for accelerometry-measured physical activity guideline adherence: Results from the German National Cohort (NAKO). Bull. World Health Organ 2026, DOI: 10.2471/BLT.25.295087

Our latest News

discover more
All Experimentica sites are now CIR-accredited

All Experimentica sites are now CIR-accredited

Experimentica’s sites have gained CIR accreditation for 2026-2028, enabling eligible French companies to benefit from CIR-covered preclinical ophthalmic research services. Experimentica’s Kuopio and Vilnius sites are now both CIR-accredited for 2026–2028. Our Kuopio site has held the accreditation since 2020, and with the addition of our Vilnius site, French biotech and pharmaceutical companies can access […]

Helmholtz Doctoral Award for Mariam Amghar

Helmholtz Doctoral Award for Mariam Amghar

In her doctoral thesis at the German Cancer Research Center (DKFZ), Mariam Amghar investigated why some prostate cancer patients respond to radioactive drugs while others do not. Her findings may help tailor treatment more effectively to individual patients in the future. Mariam Amghar has been awarded the Helmholtz Doctoral Prize in the “Health” category. At […]

Mirco Friedrich Receives the Peter and Traudl Engelhorn Foundation Award

Mirco Friedrich Receives the Peter and Traudl Engelhorn Foundation Award

Mirco Julian Friedrich, a physician and cancer researcher at the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Research Institute, and Heidelberg University Hospital (UKHD), is being honored for his outstanding research on the aging immune system and the immune response to blood cancer. Mirco Friedrich leads a junior research group at the DKFZ […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp